Tabner Andrew John, Johnson Graham David, Fakis Apostolos, Surtees Jane, Lennon Robert Iain
Emergency Department, Royal Derby Hospital, Derby, UK.
Research and Development Department, Derby Teaching Hospitals NHS Foundation Trust, Derby, UK.
BMJ Open. 2016 Jun 20;6(6):e011315. doi: 10.1136/bmjopen-2016-011315.
To determine whether β-adrenoreceptor agonists are effective analgesics for patients with renal colic through a systematic review of the literature.
Adult emergency departments or acute assessment units.
Human participants with proven or suspected renal colic.
β-adrenoreceptor agonists.
Primary: level of pain at 30 min following administration of the β-agonist. Secondary: level of pain at various time points following β-agonist administration; length of hospital stay; analgesic requirement; stone presence, size and position; degree of hydronephrosis.
256 records were screened and 4 identified for full-text review. No articles met the inclusion criteria.
There is no evidence to support or refute the proposed use of β-agonists for analgesia in patients with renal colic. Given the biological plausibility and existing literature base, clinical trials investigating the use of β-adrenoreceptor agonists in the acute setting for treatment of the pain associated with renal colic are recommended.
CRD42015016266.
通过对文献的系统综述,确定β-肾上腺素能受体激动剂对肾绞痛患者是否为有效的镇痛药。
成人急诊科或急性评估单元。
确诊或疑似肾绞痛的人类参与者。
β-肾上腺素能受体激动剂。
主要指标:给予β-激动剂后30分钟的疼痛程度。次要指标:给予β-激动剂后不同时间点的疼痛程度;住院时间;镇痛需求;结石的存在、大小和位置;肾积水程度。
筛选了256条记录,4条被确定进行全文审查。没有文章符合纳入标准。
没有证据支持或反驳在肾绞痛患者中使用β-激动剂进行镇痛的提议。鉴于其生物学合理性和现有文献基础,建议开展临床试验,研究β-肾上腺素能受体激动剂在急性情况下用于治疗肾绞痛相关疼痛的效果。
CRD42015016266。